Last reviewed · How we verify
NCT05359614
Coolsculpting With Cooltone Verses Coolsculpting Alone for the Banana Roll Area
NA trial testing CoolSculpting Elite combined with CoolTone Treatments in Improved Appearance of the Banana Roll Region in 15 participants. Status unknown.
30 August 2022
Quick facts
| Lead sponsor | Goldman, Butterwick, Fitzpatrick and Groff |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 14 March 2022 |
| Primary completion | 30 August 2022 |
| Estimated completion | 30 September 2022 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- CoolSculpting Elite combined with CoolTone Treatments
- CoolSculpting Elite
Conditions studied
- Improved Appearance of the Banana Roll Region — all drugs for Improved Appearance of the Banana Roll Region →
Sponsor
Goldman, Butterwick, Fitzpatrick and Groff — full company profile →
Who can join
Adults 22 to 65, female only, with Improved Appearance of the Banana Roll Region. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
to evaluate the benefit and efficacy of CoolSculpting Elite study treatments versus CoolSculpting Elite study treatments followed by a series CoolTone for underneath the buttocks (also known as the banana roll).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05359614
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Goldman, Butterwick, Fitzpatrick and Groff trials
Trials by the same sponsor.
- NCT07462533 — Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing · Phase 2 · not yet recruiting
- NCT07421544 — Assess Injectable Hyaluronic Acid Gel for the Treatment of Volume Loss, Skin Laxity and Fine Lines · Phase 4 · not yet recruiting
- NCT07342413 — Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the · Phase 4 · not yet recruiting
- NCT07221461 — Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists · Phase 2 · not yet recruiting
- NCT07217743 — Assess Impact of Poly-L-lactic Acid on GLP1 Subjects · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05359614 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Goldman, Butterwick, Fitzpatrick and Groff
- Last refreshed: 4 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05359614.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing